BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26967209)

  • 1. Spatial Navigation in Preclinical Alzheimer's Disease.
    Allison SL; Fagan AM; Morris JC; Head D
    J Alzheimers Dis; 2016 Feb; 52(1):77-90. PubMed ID: 26967209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a Spatial Navigation Screening Tool Sensitive to the Preclinical Alzheimer Disease Continuum.
    Allison SL; Rodebaugh TL; Johnston C; Fagan AM; Morris JC; Head D
    Arch Clin Neuropsychol; 2019 Oct; 34(7):1138-1155. PubMed ID: 31197326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
    Antonell A; Mansilla A; Rami L; Lladó A; Iranzo A; Olives J; Balasa M; Sánchez-Valle R; Molinuevo JL
    J Alzheimers Dis; 2014; 42(3):901-8. PubMed ID: 25024322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking CSF and cognition in Alzheimer's disease: Reanalysis of clinical data.
    Guhra M; Thomas C; Boedeker S; Kreisel S; Driessen M; Beblo T; Ohrmann P; Toepper M
    Exp Gerontol; 2016 Jan; 73():107-13. PubMed ID: 26585048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Profiles of Spatial Navigation Deficits In Alzheimer's Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment.
    Laczó M; Martinkovic L; Lerch O; Wiener JM; Kalinova J; Matuskova V; Nedelska Z; Vyhnalek M; Hort J; Laczó J
    Front Aging Neurosci; 2022; 14():886778. PubMed ID: 35721017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Alzheimer's disease on spatial navigation strategies.
    Parizkova M; Lerch O; Moffat SD; Andel R; Mazancova AF; Nedelska Z; Vyhnalek M; Hort J; Laczó J
    Neurobiol Aging; 2018 Apr; 64():107-115. PubMed ID: 29358117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer disease biomarkers are associated with decline in subjective memory, attention, and spatial navigation ability in clinically normal adults.
    Levine TF; Dessenberger SJ; Allison SL; Head D;
    J Int Neuropsychol Soc; 2024 May; 30(4):313-327. PubMed ID: 38014546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial navigation in normal aging and the prodromal stage of Alzheimer's disease: insights from imaging and behavioral studies.
    Lithfous S; Dufour A; Després O
    Ageing Res Rev; 2013 Jan; 12(1):201-13. PubMed ID: 22771718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual reality as allocentric/egocentric technology for the assessment of cognitive decline in the elderly.
    Morganti F; Riva G
    Stud Health Technol Inform; 2014; 196():278-84. PubMed ID: 24732522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease.
    Levine TF; Roe CM; Babulal GM; Fagan AM; Head D
    Alzheimer Dis Assoc Disord; 2022 Jan-Mar 01; 36(1):15-21. PubMed ID: 34966024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities.
    Allison S; Babulal GM; Stout SH; Barco PP; Carr DB; Fagan AM; Morris JC; Roe CM; Head D
    Alzheimer Dis Assoc Disord; 2018; 32(2):101-106. PubMed ID: 29578861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.
    Pettigrew C; Soldan A; Moghekar A; Wang MC; Gross AL; O'Brien R; Albert M
    Neuropsychologia; 2015 Nov; 78():63-72. PubMed ID: 26394023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From allo- to egocentric spatial ability in early Alzheimer's disease: a study with virtual reality spatial tasks.
    Morganti F; Stefanini S; Riva G
    Cogn Neurosci; 2013; 4(3-4):171-80. PubMed ID: 24251605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
    Alcolea D; Martínez-Lage P; Sánchez-Juan P; Olazarán J; Antúnez C; Izagirre A; Ecay-Torres M; Estanga A; Clerigué M; Guisasola MC; Sánchez Ruiz D; Marín Muñoz J; Calero M; Blesa R; Clarimón J; Carmona-Iragui M; Morenas-Rodríguez E; Rodríguez-Rodríguez E; Vázquez Higuera JL; Fortea J; Lleó A
    Neurology; 2015 Aug; 85(7):626-33. PubMed ID: 26180139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age effects on wayfinding and route learning skills.
    Head D; Isom M
    Behav Brain Res; 2010 May; 209(1):49-58. PubMed ID: 20085784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
    J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.